| __timestamp | Galapagos NV | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 581800000 |
| Thursday, January 1, 2015 | 129714000 | 671900000 |
| Friday, January 1, 2016 | 139574000 | 876700000 |
| Sunday, January 1, 2017 | 218502000 | 857900000 |
| Monday, January 1, 2018 | 322876000 | 822200000 |
| Tuesday, January 1, 2019 | 427320000 | 778200000 |
| Wednesday, January 1, 2020 | 523667000 | 512600000 |
| Friday, January 1, 2021 | 491707000 | 681000000 |
| Saturday, January 1, 2022 | 515083000 | 662200000 |
| Sunday, January 1, 2023 | 241294000 | 910700000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, research and development (R&D) are pivotal for innovation and growth. Over the past decade, Viatris Inc. and Galapagos NV have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Viatris Inc. consistently allocated a significant portion of its budget to R&D, peaking in 2023 with a 56% increase from its 2014 expenditure. This commitment underscores Viatris's dedication to advancing its pharmaceutical offerings.
Conversely, Galapagos NV exhibited a more volatile R&D spending pattern. After a steady climb, reaching a zenith in 2020, their investment saw a sharp decline by 2023, dropping by over 54% from its peak. This fluctuation may reflect strategic shifts or external market pressures.
These trends highlight the dynamic nature of R&D investments and their critical role in shaping the future of pharmaceutical companies.
Comparing Innovation Spending: Gilead Sciences, Inc. and Viatris Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Galapagos NV
Research and Development Expenses Breakdown: Viatris Inc. vs Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Viatris Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Viatris Inc. or MannKind Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending